{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-116545","form_type":"8-K","ticker":"ANIP","cik":"0001023024","company_name":"ANI PHARMACEUTICALS INC","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.269650+00:00","generated_at":"2026-06-22T00:32:06.591304+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"ANI Pharmaceuticals reports Q3 2022 results; financial details not provided in filing excerpt","bullets":["Company reported financial and operating results for Q3 2022 ended September 30, 2022.","Exhibit 99.1 contains conference call transcript but no specific financial figures in provided excerpt.","Investors should refer to full press release for revenue, EPS, and segment details."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-116545","json":"https://secwatch.observer/filing/0001104659-22-116545.json","markdown":"https://secwatch.observer/filing/0001104659-22-116545.md","text":"https://secwatch.observer/filing/0001104659-22-116545.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1023024/000110465922116545/0001104659-22-116545-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1023024/000110465922116545/tm2230118d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T00:32:06.591304+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b660a3492d3dee77d4f987b52ceac5712400b842","claim":"ANI PHARMACEUTICALS INC reported financial results for the three and nine months ended September 30, 2022.","evidence_excerpt":"On November 9, 2022, ANI Pharmaceuticals, Inc. (“ANI”) issued a press release announcing its financial and operating results for the three and nine months ended September 30, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465922116545/0001104659-22-116545-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and nine months ended September 30, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}